Leerink Partners Maintains Outperform on United Therapeutics, Raises Price Target to $725

Benzinga · 2d ago
Leerink Partners analyst Roanna Ruiz maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price target from $685 to $725.